公开(公告)号：US20200216528A1

公开(公告)日：2020-07-09

申请号：US16661783

申请日：2019-10-23

申请人： argenx BVBA

发明人： Christophe Frederic Jerome BLANCHETOT ,  Birgitte URSØ ,  Tine SKAK-NIELSEN ,  Malene BERTELSEN ,  Sebastian VAN DER WONING ,  Michael SAUNDERS ,  Johannes Joseph Wilhelmus DE HAARD

IPC分类号： C07K16/24 ,  C07K16/28 ,  A61P17/06 ,  A61P19/02 ,  A61P17/02 ,  C07K14/54 ,  C12N15/62

摘要： The present invention relates to antibodies and antigen binding fragments thereof which bind to the cytokine receptor IL-22R, particularly human IL-22R. The invention also relates to pharmaceutical compositions comprising said antibodies or antigen binding fragments thereof, and methods of treating psoriasis, psoriatic arthritis or atopic dermatitis.

公开(公告)号：US20200157207A1

公开(公告)日：2020-05-21

申请号：US16661757

申请日：2019-10-23

申请人： argenx BVBA

发明人： Christophe Frederic Jerome BLANCHETOT ,  Birgitte URSØ ,  Tine SKAK-NIELSEN ,  Malene BERTELSEN ,  Sebastian VAN DER WONING ,  Michael SAUNDERS ,  Johannes Joseph Wilhelmus DE HAARD

IPC分类号： C07K16/24 ,  C07K16/28 ,  C12N15/62 ,  C07K14/54 ,  A61P17/02 ,  A61P19/02 ,  A61P17/06

摘要： The present invention relates to antibodies and antigen binding fragments thereof which bind to the cytokine receptor IL-22R, particularly human IL-22R. The invention also relates to pharmaceutical compositions comprising said antibodies or antigen binding fragments thereof, and methods of treating psoriasis, psoriatic arthritis or atopic dermatitis.

公开(公告)号：US20230088269A1

公开(公告)日：2023-03-23

申请号：US17819161

申请日：2022-08-11

申请人： argenx BVBA

发明人： Christophe Frederic Jerome BLANCHETOT ,  Birgitte URSØ ,  Tine SKAK-NIELSEN ,  Malene BERTELSEN ,  Sebastian VAN DER WONING ,  Michael SAUNDERS ,  Johannes Joseph Wilhelmus DE HAARD

IPC分类号： C07K16/24 ,  C07K16/28 ,  A61P17/06 ,  A61P19/02 ,  A61P17/02 ,  C07K14/54 ,  C12N15/62

摘要： The present invention relates to antibodies and antigen binding fragments thereof which bind to the cytokine receptor IL-22R, particularly human IL-22R. The invention also relates to pharmaceutical compositions comprising said antibodies or antigen binding fragments thereof, and methods of treating psoriasis, psoriatic arthritis or atopic dermatitis.

公开(公告)号：US20190127459A1

公开(公告)日：2019-05-02

申请号：US16242760

申请日：2019-01-08

申请人： argenx BVBA

发明人： Christophe Frederic Jerome BLANCHETOT ,  Birgitte URSØ ,  Tine SKAK-NIELSEN ,  Malene BERTELSEN ,  Sebastian VAN DER WONING ,  Michael SAUNDERS ,  Johannes Joseph Wilhelmus DE HAARD

IPC分类号： C07K16/24 ,  A61P17/06 ,  A61P17/02 ,  A61P19/02 ,  C07K14/54 ,  C12N15/62

摘要： The present invention relates to antibodies and antigen binding fragments thereof which bind to the cytokine receptor IL-22R, particularly human IL-22R. The invention also relates to pharmaceutical compositions comprising said antibodies or antigen binding fragments thereof, and methods of treating psoriasis, psoriatic arthritis or atopic dermatitis.